Status:
COMPLETED
Double-blind Comparative Study of TAK-875
Lead Sponsor:
Takeda
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
20+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to evaluate the efficacy and safety of treatment with TAK-875 in diabetic patients.
Eligibility Criteria
Inclusion
- The participant is an outpatient.
- The participant signs and dates a written, informed consent form and any required privacy authorization prior to the initiation of any study procedures.
Exclusion
- The participant has any serious cardiac disease, serious cerebrovascular disorder, or any serious pancreatic or hematological disease.
- The participant is considered ineligible for the study for any other reason by the investigator or sub-investigator.
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2012
Estimated Enrollment :
192 Patients enrolled
Trial Details
Trial ID
NCT01433393
End Date
September 1 2012
Last Update
November 9 2012
Active Locations (19)
Enter a location and click search to find clinical trials sorted by distance.
1
Kisarazu-shi, Chiba, Japan
2
Matsuyama, Ehime, Japan
3
Fukuoka-shi Nishi-ku, Fukuoka, Japan
4
Kasuga-shi, Fukuoka, Japan